Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation

Johanna Ndamwena Amunjela; Steven John Tucker

doi:10.1042/BSR20171039

Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation

Johanna Ndamwena Amunjela, Steven John Tucker^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

8 Downloads (Pure)

Abstract

Breast cancer subtypes such as triple-negative that lack the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 receptor (HER2), remain poorly clinically managed due to a lack of therapeutic targets. This necessitates identification and validation of novel targets. Suppression of Popeye domain-containing protein 1 (POPDC1) is known to promote tumorigenesis and correlate to poor clinical outcomes in various cancers, and also promotes cardiac and skeletal muscle pathologies. It remains to be established whether POPDC1 is dysregulated in breast cancer, and whether overcoming the dysregulation of POPDC1 could present a potential therapeutic strategy to inhibit breast tumorigenesis. We assessed the potential of POPDC1 as a novel target for inhibiting breast cancer cell migration and proliferation. POPDC1 was significantly suppressed with reduced cell membrane localization in breast cancer cells. Furthermore, functional suppression of POPDC1 promoted breast cancer cell migration and proliferation, which were inhibited by POPDC1 overexpression. Finally, cAMP interacts with POPDC1 and up-regulates its expression in breast cancer cells. These findings suggest that POPDC1 plays a role in breast tumorigenesis and represents a potential therapeutic target or biomarker in breast cancer medicine.

Original language	English
Article number	BSR20171039
Journal	Bioscience Reports
Volume	37
Issue number	6
Early online date	21 Nov 2017
DOIs	https://doi.org/10.1042/BSR20171039
Publication status	Published - 22 Dec 2017

Bibliographical note

This work was funded by the University Of Aberdeen College Of Life Sciences and Medicine alongside the University of Aberdeen Elphinstone Scholarship Scheme. The authors thank Prof. Thomas Brand and Dr Roland Schindler at Imperial College London for the plasmid constructs and collaborative efforts. Finally, authors acknowledge Dr Jin Pu at the University of Aberdeen, for sharing the MCF10A and MDA231 cells.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1042/BSR20171039Licence: CC BY

Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation
https://creativecommons.org/licenses/by/4.0/
Final published version, 4.33 MBLicence: CC BY

Cite this

@article{403bb526b40a42b282c235d237de445b,

title = "Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation",

abstract = "Breast cancer subtypes such as triple-negative that lack the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 receptor (HER2), remain poorly clinically managed due to a lack of therapeutic targets. This necessitates identification and validation of novel targets. Suppression of Popeye domain-containing protein 1 (POPDC1) is known to promote tumorigenesis and correlate to poor clinical outcomes in various cancers, and also promotes cardiac and skeletal muscle pathologies. It remains to be established whether POPDC1 is dysregulated in breast cancer, and whether overcoming the dysregulation of POPDC1 could present a potential therapeutic strategy to inhibit breast tumorigenesis. We assessed the potential of POPDC1 as a novel target for inhibiting breast cancer cell migration and proliferation. POPDC1 was significantly suppressed with reduced cell membrane localization in breast cancer cells. Furthermore, functional suppression of POPDC1 promoted breast cancer cell migration and proliferation, which were inhibited by POPDC1 overexpression. Finally, cAMP interacts with POPDC1 and up-regulates its expression in breast cancer cells. These findings suggest that POPDC1 plays a role in breast tumorigenesis and represents a potential therapeutic target or biomarker in breast cancer medicine.",

author = "Amunjela, {Johanna Ndamwena} and Tucker, {Steven John}",

note = "This work was funded by the University Of Aberdeen College Of Life Sciences and Medicine alongside the University of Aberdeen Elphinstone Scholarship Scheme. The authors thank Prof. Thomas Brand and Dr Roland Schindler at Imperial College London for the plasmid constructs and collaborative efforts. Finally, authors acknowledge Dr Jin Pu at the University of Aberdeen, for sharing the MCF10A and MDA231 cells.",

year = "2017",

month = dec,

day = "22",

doi = "10.1042/BSR20171039",

language = "English",

volume = "37",

journal = "Bioscience Reports",

issn = "0144-8463",

publisher = "Portland Press Ltd.",

number = "6",

}

TY - JOUR

T1 - Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation

AU - Amunjela, Johanna Ndamwena

AU - Tucker, Steven John

N1 - This work was funded by the University Of Aberdeen College Of Life Sciences and Medicine alongside the University of Aberdeen Elphinstone Scholarship Scheme. The authors thank Prof. Thomas Brand and Dr Roland Schindler at Imperial College London for the plasmid constructs and collaborative efforts. Finally, authors acknowledge Dr Jin Pu at the University of Aberdeen, for sharing the MCF10A and MDA231 cells.

PY - 2017/12/22

Y1 - 2017/12/22

N2 - Breast cancer subtypes such as triple-negative that lack the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 receptor (HER2), remain poorly clinically managed due to a lack of therapeutic targets. This necessitates identification and validation of novel targets. Suppression of Popeye domain-containing protein 1 (POPDC1) is known to promote tumorigenesis and correlate to poor clinical outcomes in various cancers, and also promotes cardiac and skeletal muscle pathologies. It remains to be established whether POPDC1 is dysregulated in breast cancer, and whether overcoming the dysregulation of POPDC1 could present a potential therapeutic strategy to inhibit breast tumorigenesis. We assessed the potential of POPDC1 as a novel target for inhibiting breast cancer cell migration and proliferation. POPDC1 was significantly suppressed with reduced cell membrane localization in breast cancer cells. Furthermore, functional suppression of POPDC1 promoted breast cancer cell migration and proliferation, which were inhibited by POPDC1 overexpression. Finally, cAMP interacts with POPDC1 and up-regulates its expression in breast cancer cells. These findings suggest that POPDC1 plays a role in breast tumorigenesis and represents a potential therapeutic target or biomarker in breast cancer medicine.

AB - Breast cancer subtypes such as triple-negative that lack the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 receptor (HER2), remain poorly clinically managed due to a lack of therapeutic targets. This necessitates identification and validation of novel targets. Suppression of Popeye domain-containing protein 1 (POPDC1) is known to promote tumorigenesis and correlate to poor clinical outcomes in various cancers, and also promotes cardiac and skeletal muscle pathologies. It remains to be established whether POPDC1 is dysregulated in breast cancer, and whether overcoming the dysregulation of POPDC1 could present a potential therapeutic strategy to inhibit breast tumorigenesis. We assessed the potential of POPDC1 as a novel target for inhibiting breast cancer cell migration and proliferation. POPDC1 was significantly suppressed with reduced cell membrane localization in breast cancer cells. Furthermore, functional suppression of POPDC1 promoted breast cancer cell migration and proliferation, which were inhibited by POPDC1 overexpression. Finally, cAMP interacts with POPDC1 and up-regulates its expression in breast cancer cells. These findings suggest that POPDC1 plays a role in breast tumorigenesis and represents a potential therapeutic target or biomarker in breast cancer medicine.

UR - http://www.scopus.com/inward/record.url?scp=85039847001&partnerID=8YFLogxK

U2 - 10.1042/BSR20171039

DO - 10.1042/BSR20171039

M3 - Article

AN - SCOPUS:85039847001

SN - 0144-8463

VL - 37

JO - Bioscience Reports

JF - Bioscience Reports

IS - 6

M1 - BSR20171039

ER -

Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this